v3.26.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities:    
Net income $ 73,633 $ 27,815
Adjustments to reconcile net income to net cash from operating activities:    
Depreciation and amortization 11,382 12,908
Bad debt provision 4,455 79,012
Deferred income taxes 606 15,939
Share-based compensation expense 8,527 8,881
Accretion of discounts/amortization of premium on marketable securities, net (21) 359
Unrealized gain on deferred compensation fund investments (4,789) (6,926)
Changes in other long-term assets and liabilities 814 (384)
Net loss on disposals of property and equipment 313 253
Share of losses from equity method investment 92 2,386
Changes in operating assets and liabilities:    
Accounts and notes receivable (41,504) 5,255
Inventories and supplies 1,261 (453)
Prepaid expenses and other assets (8,778) (3,603)
Deferred compensation funding 1,438 469
Accounts payable and other accrued expenses 5,080 (5,310)
Accrued payroll and related taxes 23,786 (134)
Deferred ERC credits 0 12,276
Taxes receivable/payable 23,979 (23,953)
Accrued insurance claims (8,035) (4,115)
Deferred compensation liability 3,531 6,906
Net cash from operating activities 95,770 127,581
Cash flows from investing activities:    
Disposals of property and equipment 160 86
Additions to property and equipment (5,097) (4,438)
Cash paid for acquisitions, net of cash acquired (22,858) (7,287)
Cash paid for equity investments (4,625) (2,125)
Purchases of marketable securities (21,345) (13,884)
Sales of marketable securities 21,242 8,082
Net cash from investing activities (32,523) (19,566)
Cash flows from financing activities:    
Purchases of treasury stock (56,628) (41,982)
Payments of statutory withholding on net issuance of restricted stock units (4,162) (1,744)
Proceeds from the exercise of stock options 1,490 0
Net cash from financing activities (59,300) (43,726)
Net increase in cash, cash equivalents and restricted cash equivalents 3,947 64,289
Cash, cash equivalents and restricted cash equivalents at beginning of the period 130,766 60,131
Cash, cash equivalents and restricted cash equivalents at end of the period $ 134,713 $ 124,420